Clinical trials
Not yet recruiting Obesity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 70 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 86 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| Eli Lilly and Company | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| University of Alabama at Birmingham | 3 |
| Indiana University | 2 |
| Massachusetts General Hospital | 2 |
| Medical College of Wisconsin | 2 |
| Medical University of South Carolina | 2 |
| Novo Nordisk A/S | 2 |
| Pennington Biomedical Research Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 86 |
| Overweight | 39 |
| Weight Loss | 13 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 7 |
| Body Weight | 6 |
| Hypertension | 5 |
| Insulin Resistance | 5 |
| Dyslipidemias | 4 |
| Prediabetic State | 4 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.